HEADER TRANSFERASE 21-MAR-17 5NHJ TITLE HUMAN ERK2 WITH AN ERK1/2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2, COMPND 5 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2, COMPND 6 MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ERK2, KINASE, INHIBITOR, ONCOLOGY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI,R.A.WARD,P.BETHEL,C.COOK,E.DAVIES,K.ECKERSLEY, AUTHOR 2 G.FAIRLEY,L.FERON,V.FLEMINGTON,M.A.GRAHAM,R.GREENWOOD,P.HOPCROFT, AUTHOR 3 T.D.HOWARD,J.HUDSON,M.JAMES,C.D.JONES,C.R.JONES,S.LAMONT,R.LEWIS, AUTHOR 4 N.LINDSAY,K.ROBERTS,I.SIMPSON,S.STGALLAY,S.SWALLOW,M.TONGE REVDAT 2 10-MAY-17 5NHJ 1 JRNL REVDAT 1 19-APR-17 5NHJ 0 JRNL AUTH R.A.WARD,P.BETHEL,C.COOK,E.DAVIES,J.E.DEBRECZENI,G.FAIRLEY, JRNL AUTH 2 L.FERON,V.FLEMINGTON,M.A.GRAHAM,R.GREENWOOD,N.GRIFFIN, JRNL AUTH 3 L.HANSON,P.HOPCROFT,T.D.HOWARD,J.HUDSON,M.JAMES,C.D.JONES, JRNL AUTH 4 C.R.JONES,S.LAMONT,R.LEWIS,N.LINDSAY,K.ROBERTS,I.SIMPSON, JRNL AUTH 5 S.ST-GALLAY,S.SWALLOW,J.TANG,M.TONGE,Z.WANG,B.ZHAI JRNL TITL STRUCTURE-GUIDED DISCOVERY OF POTENT AND SELECTIVE JRNL TITL 2 INHIBITORS OF ERK1/2 FROM A MODESTLY ACTIVE AND PROMISCUOUS JRNL TITL 3 CHEMICAL START POINT. JRNL REF J. MED. CHEM. V. 60 3438 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28376306 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00267 REMARK 2 REMARK 2 RESOLUTION. 2.12 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 21726 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1108 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.22 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.23 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2645 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2440 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2507 REMARK 3 BIN R VALUE (WORKING SET) : 0.2440 REMARK 3 BIN FREE R VALUE : 0.2440 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 138 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2737 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 187 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.34 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.46650 REMARK 3 B22 (A**2) : 0.42970 REMARK 3 B33 (A**2) : 2.03690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.12480 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.290 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.238 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.163 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.235 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.163 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2842 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3871 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 962 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 69 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 436 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2842 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 373 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3419 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.17 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.10 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -6.7050 8.6514 47.1575 REMARK 3 T TENSOR REMARK 3 T11: -0.1424 T22: -0.1348 REMARK 3 T33: -0.0957 T12: -0.0057 REMARK 3 T13: 0.0228 T23: 0.0050 REMARK 3 L TENSOR REMARK 3 L11: 0.8540 L22: 0.5363 REMARK 3 L33: 1.1225 L12: 0.2436 REMARK 3 L13: 0.2784 L23: 0.2329 REMARK 3 S TENSOR REMARK 3 S11: -0.0406 S12: 0.0683 S13: 0.0334 REMARK 3 S21: -0.0656 S22: 0.0034 S23: 0.0238 REMARK 3 S31: -0.0524 S32: 0.0606 S33: 0.0372 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NHJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1200004143. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21741 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.120 REMARK 200 RESOLUTION RANGE LOW (A) : 45.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.72300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEGMME2K, 100MM HEPES PH 7.6, REMARK 280 200MM AMMONIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.57900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 GLY A -11 REMARK 465 GLY A -10 REMARK 465 GLY A -9 REMARK 465 GLU A -8 REMARK 465 ASN A -7 REMARK 465 LEU A -6 REMARK 465 TYR A -5 REMARK 465 PHE A -4 REMARK 465 GLN A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 PRO A 356 REMARK 465 GLY A 357 REMARK 465 TYR A 358 REMARK 465 ARG A 359 REMARK 465 SER A 360 REMARK 465 LEU A 361 REMARK 465 GLU A 362 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 12 CG CD OE1 OE2 REMARK 470 MET A 13 CG SD CE REMARK 470 LEU A 46 CG CD1 CD2 REMARK 470 LYS A 48 CG CD CE NZ REMARK 470 LYS A 99 CG CD CE NZ REMARK 470 LYS A 114 CE NZ REMARK 470 LYS A 117 CD CE NZ REMARK 470 GLU A 186 CG CD OE1 OE2 REMARK 470 ARG A 225 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 250 CG CD OE1 OE2 REMARK 470 LYS A 270 CG CD CE NZ REMARK 470 ARG A 277 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 300 CD CE NZ REMARK 470 LYS A 330 CG CD CE NZ REMARK 470 PHE A 331 CG CD1 CD2 CE1 CE2 CZ REMARK 470 MET A 333 CG SD CE REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 ASP A 336 CG OD1 OD2 REMARK 470 ASP A 337 CG OD1 OD2 REMARK 470 LYS A 340 CG CD CE NZ REMARK 470 GLU A 349 CG CD OE1 OE2 REMARK 470 ARG A 353 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ALA A 189 NH2 ARG A 194 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 23 C - N - CD ANGL. DEV. = 18.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 46 -0.49 81.98 REMARK 500 ASP A 149 35.90 -155.95 REMARK 500 ASP A 167 76.52 60.64 REMARK 500 ASN A 201 15.20 -149.97 REMARK 500 LEU A 294 59.82 -91.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 686 DISTANCE = 6.40 ANGSTROMS REMARK 525 HOH A 687 DISTANCE = 6.43 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8XE A 403 DBREF 5NHJ A 1 360 UNP P28482 MK01_HUMAN 1 360 SEQADV 5NHJ MET A -18 UNP P28482 INITIATING METHIONINE SEQADV 5NHJ HIS A -17 UNP P28482 EXPRESSION TAG SEQADV 5NHJ HIS A -16 UNP P28482 EXPRESSION TAG SEQADV 5NHJ HIS A -15 UNP P28482 EXPRESSION TAG SEQADV 5NHJ HIS A -14 UNP P28482 EXPRESSION TAG SEQADV 5NHJ HIS A -13 UNP P28482 EXPRESSION TAG SEQADV 5NHJ HIS A -12 UNP P28482 EXPRESSION TAG SEQADV 5NHJ GLY A -11 UNP P28482 EXPRESSION TAG SEQADV 5NHJ GLY A -10 UNP P28482 EXPRESSION TAG SEQADV 5NHJ GLY A -9 UNP P28482 EXPRESSION TAG SEQADV 5NHJ GLU A -8 UNP P28482 EXPRESSION TAG SEQADV 5NHJ ASN A -7 UNP P28482 EXPRESSION TAG SEQADV 5NHJ LEU A -6 UNP P28482 EXPRESSION TAG SEQADV 5NHJ TYR A -5 UNP P28482 EXPRESSION TAG SEQADV 5NHJ PHE A -4 UNP P28482 EXPRESSION TAG SEQADV 5NHJ GLN A -3 UNP P28482 EXPRESSION TAG SEQADV 5NHJ GLY A -2 UNP P28482 EXPRESSION TAG SEQADV 5NHJ SER A -1 UNP P28482 EXPRESSION TAG SEQADV 5NHJ HIS A 0 UNP P28482 EXPRESSION TAG SEQADV 5NHJ LEU A 46 UNP P28482 VAL 46 CONFLICT SEQADV 5NHJ LEU A 361 UNP P28482 EXPRESSION TAG SEQADV 5NHJ GLU A 362 UNP P28482 EXPRESSION TAG SEQRES 1 A 381 MET HIS HIS HIS HIS HIS HIS GLY GLY GLY GLU ASN LEU SEQRES 2 A 381 TYR PHE GLN GLY SER HIS MET ALA ALA ALA ALA ALA ALA SEQRES 3 A 381 GLY ALA GLY PRO GLU MET VAL ARG GLY GLN VAL PHE ASP SEQRES 4 A 381 VAL GLY PRO ARG TYR THR ASN LEU SER TYR ILE GLY GLU SEQRES 5 A 381 GLY ALA TYR GLY MET VAL CYS SER ALA TYR ASP ASN LEU SEQRES 6 A 381 ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SER PRO PHE SEQRES 7 A 381 GLU HIS GLN THR TYR CYS GLN ARG THR LEU ARG GLU ILE SEQRES 8 A 381 LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE GLY SEQRES 9 A 381 ILE ASN ASP ILE ILE ARG ALA PRO THR ILE GLU GLN MET SEQRES 10 A 381 LYS ASP VAL TYR ILE VAL GLN ASP LEU MET GLU THR ASP SEQRES 11 A 381 LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SER ASN ASP SEQRES 12 A 381 HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG GLY LEU SEQRES 13 A 381 LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG ASP LEU SEQRES 14 A 381 LYS PRO SER ASN LEU LEU LEU ASN THR THR CYS ASP LEU SEQRES 15 A 381 LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA ASP PRO SEQRES 16 A 381 ASP HIS ASP HIS THR GLY PHE LEU THR GLU TYR VAL ALA SEQRES 17 A 381 THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SER SEQRES 18 A 381 LYS GLY TYR THR LYS SER ILE ASP ILE TRP SER VAL GLY SEQRES 19 A 381 CYS ILE LEU ALA GLU MET LEU SER ASN ARG PRO ILE PHE SEQRES 20 A 381 PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE LEU SEQRES 21 A 381 GLY ILE LEU GLY SER PRO SER GLN GLU ASP LEU ASN CYS SEQRES 22 A 381 ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SER LEU SEQRES 23 A 381 PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE PRO SEQRES 24 A 381 ASN ALA ASP SER LYS ALA LEU ASP LEU LEU ASP LYS MET SEQRES 25 A 381 LEU THR PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU GLN SEQRES 26 A 381 ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP PRO SEQRES 27 A 381 SER ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE ASP SEQRES 28 A 381 MET GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS GLU SEQRES 29 A 381 LEU ILE PHE GLU GLU THR ALA ARG PHE GLN PRO GLY TYR SEQRES 30 A 381 ARG SER LEU GLU HET SO4 A 401 5 HET SO4 A 402 5 HET 8XE A 403 27 HETNAM SO4 SULFATE ION HETNAM 8XE 5-(2-METHOXYETHYL)-2-[2-[(2-METHYLPYRAZOL-3-YL) HETNAM 2 8XE AMINO]PYRIMIDIN-4-YL]-6,7-DIHYDRO-1~{H}-PYRROLO[3,2- HETNAM 3 8XE C]PYRIDIN-4-ONE FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 8XE C18 H21 N7 O2 FORMUL 5 HOH *187(H2 O) HELIX 1 AA1 HIS A 61 PHE A 78 1 18 HELIX 2 AA2 LEU A 112 LYS A 117 1 6 HELIX 3 AA3 SER A 122 ALA A 143 1 22 HELIX 4 AA4 LYS A 151 SER A 153 5 3 HELIX 5 AA5 ASP A 175 ASP A 179 5 5 HELIX 6 AA6 THR A 190 ARG A 194 5 5 HELIX 7 AA7 ALA A 195 ASN A 201 1 7 HELIX 8 AA8 LYS A 207 ASN A 224 1 18 HELIX 9 AA9 LEU A 234 GLY A 245 1 12 HELIX 10 AB1 SER A 248 CYS A 254 1 7 HELIX 11 AB2 ASN A 257 SER A 266 1 10 HELIX 12 AB3 PRO A 274 PHE A 279 1 6 HELIX 13 AB4 ASP A 283 LEU A 294 1 12 HELIX 14 AB5 GLU A 303 ALA A 309 1 7 HELIX 15 AB6 HIS A 310 GLU A 314 5 5 HELIX 16 AB7 ASP A 318 GLU A 322 5 5 HELIX 17 AB8 PRO A 339 THR A 351 1 13 HELIX 18 AB9 ALA A 352 GLN A 355 5 4 SHEET 1 AA1 2 GLU A 12 VAL A 14 0 SHEET 2 AA1 2 GLN A 17 PHE A 19 -1 O GLN A 17 N VAL A 14 SHEET 1 AA2 5 TYR A 25 GLU A 33 0 SHEET 2 AA2 5 GLY A 37 ASP A 44 -1 O TYR A 43 N THR A 26 SHEET 3 AA2 5 ARG A 50 ILE A 56 -1 O LYS A 55 N MET A 38 SHEET 4 AA2 5 VAL A 101 ASP A 106 -1 O GLN A 105 N ALA A 52 SHEET 5 AA2 5 ASP A 88 ILE A 90 -1 N ASP A 88 O VAL A 104 SHEET 1 AA3 3 THR A 110 ASP A 111 0 SHEET 2 AA3 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 AA3 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 AA4 2 VAL A 145 LEU A 146 0 SHEET 2 AA4 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 CISPEP 1 GLY A 22 PRO A 23 0 0.00 SITE 1 AC1 3 ARG A 191 ARG A 194 HOH A 588 SITE 1 AC2 4 ALA A 35 ARG A 67 HOH A 505 HOH A 565 SITE 1 AC3 11 GLY A 37 ALA A 52 LYS A 54 ASP A 106 SITE 2 AC3 11 MET A 108 GLU A 109 ASP A 111 LEU A 156 SITE 3 AC3 11 ASP A 167 HOH A 513 HOH A 524 CRYST1 49.025 71.158 61.398 90.00 112.03 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020398 0.000000 0.008254 0.00000 SCALE2 0.000000 0.014053 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017570 0.00000